Abstract B184: Leveraging the BRIDGE framework to transform breast cancer diagnosis in ub-Saharan Africa
Abstract
Breast cancer represents the leading cause of cancer-related mortality among women in sub-Saharan Africa (SSA), with incidence rates reaching 53.2 per 100,000 in Northern Africa and mortality rates of 22.6 per 100,000 in Western Africa (GLOBOCAN). Over 70% of cases are diagnosed at advanced stages, reflecting structural deficiencies in early detection, molecular characterization, and diagnostic system integration. These disparities are compounded by limited access to pathology services, biomarker testing, and genomically informed risk stratification, thereby constraining the implementation of precision oncology across SSA. We performed a systems-level evaluation of the diagnostic continuum in SSA, integrating conventional diagnostic modalities such as clinical breast examination, radiologic imaging, histopathology, and tissue biopsy with emerging technologies including liquid biopsy, multi-omics profiling, digital pathology, and artificial intelligence–assisted image analysis. Barriers were examined across biological, infrastructural, workforce, and health systems domains to define intervention nodes amenable to translational optimization. We identify critical mechanistic bottlenecks across the diagnostic cascade, including delayed tumor detection, limited access to molecular subtyping (ER/PR/HER2), inadequate biomarker-driven treatment stratification, and fragmented referral networks. These constraints perpetuate late-stage presentation and biologically aggressive disease phenotypes at diagnosis. To address these gaps, we propose the BRIDGE Framework: Build community-level awareness to shift stage distribution; Reinforce primary care triage and diagnostic referral algorithms; Innovate through deployment of cost-adapted molecular and digital diagnostics; implement Data-driven surveillance and implementation science metrics; strengthen Governance and sustainable financing; and Engage multidisciplinary translational ecosystems. Leveraging the BRIDGE Framework provides a mechanistically informed, implementation-oriented roadmap to transform breast cancer diagnostics in SSA. By integrating molecular profiling, systems biology approaches, and context-adapted technological innovation, this strategy aligns with the WHO Global Breast Cancer Initiative and advances equitable precision oncology. Such a transformation has the potential to shift the stage at diagnosis, enable biomarker-guided therapy, and reduce mortality disparities across African populations. John Oluwafemi . Teibo, Oluwatomiwa Kehinde Paimo, Tolulope Oladimeji, Titilade Kehinde Ayandeyi Teibo, Olabode Omotoso. Leveraging the BRIDGE framework to transform breast cancer diagnosis in ub-Saharan Africa [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr B184.